Beam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. You will partner closely with business development, alliance management, finance, investor relations, and human resources, and manage outside counsel to help support Beam’s continued growth and evolution as it makes progress toward becoming a commercial-stage company.